公开(公告)号：NZ526313A

公开(公告)日：2004-11-26

申请号：NZ52631301

申请日：2001-11-30

Applicant: ABBOTT LAB

Inventor： CLAIBORNE AKIYO K ,  GWALTNEY STEPHEN L ,  HASVOLD LISA A ,  LI QUN ,  LI TOMGMEI ,  LIN NAN-HORNG ,  MANTEI ROBERT A ,  ROCKWAY TODD W ,  SHAM HING L ,  SULLIVAN GERARD M ,  TONG YUNSONG ,  WANG GARY T ,  WANG LE ,  WANG XILU ,  WANG WEIBO

IPC: A61K31/4164 ,  A61K31/4178 ,  A61K31/426 ,  A61K31/4439 ,  A61K31/4709 ,  A61P35/00 ,  A61P43/00 ,  C07D233/54 ,  C07D233/64 ,  C07D277/20 ,  C07D277/30 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12

Abstract: A compound of formula (I); a pharmaceutical composition comprising the compound; the use of the compound in the preparation of a medicament for inhibiting farnesyltransferase in a patient in need of such treatment; and the use of the compound in the preparation of a medicament for treating cancer in a patient.

公开(公告)号：BG107908A

公开(公告)日：2004-01-30

申请号：BG10790803

申请日：2003-06-13

Applicant: ABBOTT LAB

Inventor： CLAIBORNE AKYO K ,  GWALTNEY II STEPHEN L ,  HASVOLD LISA A ,  LI QUN ,  LI TOMGMEI ,  LIN NAN-HORNG ,  MANTEI ROBERT A ,  ROCKWAY TODD W ,  SHAM HING L ,  SULLIVAN GERARD M ,  TONG YUNSONG ,  WANG GARY T ,  WANG LE ,  WANG XILU ,  WANG WEIBO

IPC: A61K31/4164 ,  A61K31/4178 ,  A61K31/426 ,  A61K31/4439 ,  A61K31/4709 ,  A61P35/00 ,  A61P43/00 ,  C07D233/54 ,  C07D233/64 ,  C07D277/20 ,  C07D277/30 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12

Abstract: Substituted imidazoles and thiazoles having formula are used for inhibiting farnesyltransferase. Also disclosed are farnesylransferase-inhibiting compositions and methods of inhibiting farnesyltransferase in a patient. 10 claims

公开(公告)号：NO20032471L

公开(公告)日：2003-07-25

申请号：NO20032471

申请日：2003-05-30

Applicant: ABBOTT LAB

Inventor： CLAIBORNE AKIYO K ,  GWALTNEY II STEPHEN L ,  HASVOLD LISA A ,  LI QUN ,  LI TOMGMEI ,  LIN NAN-HORNG ,  MANTEI ROBERT A ,  ROCKWAY TODD W ,  SHAM HING L ,  SULLIVAN GERARD M ,  TONG YUNSONG ,  WANG GARY T ,  WANG LE ,  WANG XILU ,  WANG WEIBO

IPC: A61K31/4164 ,  A61K31/4178 ,  A61K31/426 ,  A61K31/4439 ,  A61K31/4709 ,  A61P35/00 ,  A61P43/00 ,  C07D233/54 ,  C07D233/64 ,  C07D277/20 ,  C07D277/30 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12

Abstract: Substituted imidazoles and thiazoles having the formula are useful for inhibiting farnesyltransferase. Also disclosed are farnesyltransferase-inhibiting compositions and methods of inhibiting farnesyltransferase in a patient.

公开(公告)号：NO20032471D0

公开(公告)日：2003-05-30

申请号：NO20032471

申请日：2003-05-30

Applicant: ABBOTT LAB

Inventor： CLAIBORNE AKIYO K ,  GWALTNEY II STEPHEN L ,  HASVOLD LISA A ,  LI QUN ,  LI TOMGMEI ,  LIN NAN-HORNG ,  MANTEI ROBERT A ,  ROCKWAY TODD W ,  SHAM HING L ,  SULLIVAN GERARD M ,  TONG YUNSONG ,  WANG GARY T ,  WANG LE ,  WANG XILU ,  WANG WEIBO

IPC: A61K31/4164 ,  A61K31/4178 ,  A61K31/426 ,  A61K31/4439 ,  A61K31/4709 ,  A61P35/00 ,  A61P43/00 ,  C07D233/54 ,  C07D233/64 ,  C07D277/20 ,  C07D277/30 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12 ,  C07D

Abstract: Substituted imidazoles and thiazoles having the formula are useful for inhibiting farnesyltransferase. Also disclosed are farnesyltransferase-inhibiting compositions and methods of inhibiting farnesyltransferase in a patient.

公开(公告)号：UY27046A1

公开(公告)日：2002-07-31

申请号：UY27046

申请日：2001-11-29

Applicant: ABBOTT LAB

Inventor： WANG GARY T ,  HASVOLD LISA A ,  SHAM HING L ,  SULLIVAN GERARD M ,  CLAIBORNE AKIYO ,  LI QUN ,  MANTEI ROBERT A ,  WANG LE ,  GWALTNEY STEPHEN ,  LI TONGMEI ,  ROCKWAY TODD W ,  TONG YUNSONG ,  WANG XILO ,  LIN NAN-HORNG ,  WANG WEIBO

IPC: A61K31/4164 ,  A61K31/4178 ,  A61K31/426 ,  A61K31/4439 ,  A61K31/4709 ,  A61P35/00 ,  A61P43/00 ,  C07D233/54 ,  C07D233/64 ,  C07D277/20 ,  C07D277/30 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12 ,  A61K31/00

Abstract: Imidazol y tiazoles sustituidos que tienen la fórmula (I) son útiles para inhibir la farnesiltransferasa. También se revelan composiciones inhibidoras de la farnesiltransferasa y métodos para inhibir la farnesiltransferasa en un paciente.

公开(公告)号：CA1337909C

公开(公告)日：1996-01-09

申请号：CA615201

申请日：1989-09-29

Applicant: ABBOTT LAB

Inventor： FUNG ANTHONY K L ,  PLATTNER JACOB J ,  BAKER WILLIAM R ,  BOYD STEVEN A ,  ARMIGER YOEK-LIN ,  KEMPF DALE J ,  ROSENBERG SAUL H ,  SHAM HING LEUNG ,  DE BISWANATH ,  KLEINERT HOLLIS D ,  MANTEI ROBERT A

IPC: A61K31/16 ,  A61K31/19 ,  A61K31/265 ,  A61K31/415 ,  A61K31/4166 ,  A61K31/445 ,  A61K31/4465 ,  A61K31/66 ,  A61P9/00 ,  A61P9/12 ,  A61P43/00 ,  C07C237/08 ,  C07C237/22 ,  C07C317/28 ,  C07C323/57 ,  C07C323/58 ,  C07D203/18 ,  C07D211/44 ,  C07D211/46 ,  C07D211/62 ,  C07D211/96 ,  C07D233/36 ,  C07D233/54 ,  C07D233/56 ,  C07D263/22 ,  C07D295/185 ,  C07D401/12 ,  C07D407/12 ,  C07D413/12 ,  C07D521/00

Abstract: A renin inhibiting compound of the formula: wherein A is a substituent; R1 is hydrogen, loweralkyl, substituted loweralkyl or loweralkenyl; X is CH2, CHOH, C(O), O, S, S(O), SO2, NH, N(O) or -P(O)O-; R3 is loweralkyl, loweralkenyl or substituted loweralkyl; and T is mimic of the Leu-Val cleavage site of angiotensinogen; or a pharmaceutically acceptable salt, ester or prodrug thereof.

公开(公告)号：NZ230894A

公开(公告)日：1991-07-26

申请号：NZ23089489

申请日：1989-10-04

Applicant: ABBOTT LAB

Inventor： FUNG ANTHONY K L ,  PLATTNER JACOB J ,  BAKER WILLIAM R ,  BOYD STEPHEN A ,  ARMIGER YOEK-LIN ,  KEMPF DALE J ,  ROSENBERG SAUL H ,  HING LEUNG SHAM ,  DE BISWANATH ,  KLEINERT HOLLIS D ,  MANTEI ROBERT A

IPC: A61K31/16 ,  A61K31/19 ,  A61K31/265 ,  A61K31/415 ,  A61K31/4166 ,  A61K31/445 ,  A61K31/4465 ,  A61K31/66 ,  A61P9/00 ,  A61P9/12 ,  A61P43/00 ,  C07C237/08 ,  C07C237/22 ,  C07C317/28 ,  C07C323/57 ,  C07C323/58 ,  C07D203/18 ,  C07D211/44 ,  C07D211/46 ,  C07D211/62 ,  C07D211/96 ,  C07D233/36 ,  C07D233/54 ,  C07D233/56 ,  C07D263/22 ,  C07D295/185 ,  C07D401/12 ,  C07D407/12 ,  C07D413/12 ,  C07D521/00 ,  C07D405/12 ,  C07D265/30 ,  C07D205/04 ,  C07D207/10 ,  C07D211/48 ,  C07D307/16 ,  C07D317/04 ,  C07D317/14 ,  C07K5/06 ,  C07C215/08 ,  C07C215/12 ,  C07C215/14 ,  C07C229/10 ,  C07C237/06 ,  C07C237/10 ,  C07C237/12 ,  C07C237/14 ,  C07C307/02 ,  C07C311/05 ,  C07C317/24 ,  C07C317/26 ,  C07F7/02 ,  C07F9/22 ,  A61K31/535

Abstract: A renin inhibiting compound of the formula: wherein A is a substituent; R1 is hydrogen, loweralkyl, substituted loweralkyl or loweralkenyl; X is CH2, CHOH, C(O), O, S, S(O), SO2, NH, N(O) or -P(O)O-; R3 is loweralkyl, loweralkenyl or substituted loweralkyl; and T is mimic of the Leu-Val cleavage site of angiotensinogen; or a pharmaceutically acceptable salt, ester or prodrug thereof.